Italian position paper on urticaria

P. D. Pigatto, C. B. Marsili, F. Ayala, O. Depità, C. Gelmetti, A. Giannetti, G. Girolomoni, G. A. Vena, N. Cassano, F. Ayala

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The Italian Board on Urticaria has prepared a document focusing on the definition and classification of urticaria, taking into account the recent progress in identifying the causes, eliciting factors, and pathomechanisms of this disease. As urticaria has a profound impact on the quality of life, effective treatment is important. Therefore, specific treatment options for the management of urticaria are evaluated on the basis of the recent literature. Non-sedating H1 antihistamines are recommended as the first-line treatment as they have proven effective in several randomized double-blind controlled studies. Dosages higher than those recommended may be necessary in some cases. However, additional or alternative therapies may be required for different urticaria subtypes and in view of individual variations in the course of the disease and response to treatment. Immunosuppressive drugs such as corticosteroids are not recommended for long-term treatment due to unavoidable, severe adverse effects.

Original languageEnglish
Pages (from-to)297-311
Number of pages15
JournalGiornale Italiano di Dermatologia e Venereologia
Volume144
Issue number3
Publication statusPublished - 2009

Fingerprint

Urticaria
Non-Sedating Histamine H1 Antagonists
Therapeutics
Immunosuppressive Agents
Complementary Therapies
Double-Blind Method
Adrenal Cortex Hormones
Quality of Life
Pharmaceutical Preparations

Keywords

  • Adrenal cortex hormones
  • Immunosuppressive agents
  • Urticaria

ASJC Scopus subject areas

  • Dermatology

Cite this

Pigatto, P. D., Marsili, C. B., Ayala, F., Depità, O., Gelmetti, C., Giannetti, A., ... Ayala, F. (2009). Italian position paper on urticaria. Giornale Italiano di Dermatologia e Venereologia, 144(3), 297-311.

Italian position paper on urticaria. / Pigatto, P. D.; Marsili, C. B.; Ayala, F.; Depità, O.; Gelmetti, C.; Giannetti, A.; Girolomoni, G.; Vena, G. A.; Cassano, N.; Ayala, F.

In: Giornale Italiano di Dermatologia e Venereologia, Vol. 144, No. 3, 2009, p. 297-311.

Research output: Contribution to journalArticle

Pigatto, PD, Marsili, CB, Ayala, F, Depità, O, Gelmetti, C, Giannetti, A, Girolomoni, G, Vena, GA, Cassano, N & Ayala, F 2009, 'Italian position paper on urticaria', Giornale Italiano di Dermatologia e Venereologia, vol. 144, no. 3, pp. 297-311.
Pigatto PD, Marsili CB, Ayala F, Depità O, Gelmetti C, Giannetti A et al. Italian position paper on urticaria. Giornale Italiano di Dermatologia e Venereologia. 2009;144(3):297-311.
Pigatto, P. D. ; Marsili, C. B. ; Ayala, F. ; Depità, O. ; Gelmetti, C. ; Giannetti, A. ; Girolomoni, G. ; Vena, G. A. ; Cassano, N. ; Ayala, F. / Italian position paper on urticaria. In: Giornale Italiano di Dermatologia e Venereologia. 2009 ; Vol. 144, No. 3. pp. 297-311.
@article{b880cd593cee497e834646e4df7cd9fb,
title = "Italian position paper on urticaria",
abstract = "The Italian Board on Urticaria has prepared a document focusing on the definition and classification of urticaria, taking into account the recent progress in identifying the causes, eliciting factors, and pathomechanisms of this disease. As urticaria has a profound impact on the quality of life, effective treatment is important. Therefore, specific treatment options for the management of urticaria are evaluated on the basis of the recent literature. Non-sedating H1 antihistamines are recommended as the first-line treatment as they have proven effective in several randomized double-blind controlled studies. Dosages higher than those recommended may be necessary in some cases. However, additional or alternative therapies may be required for different urticaria subtypes and in view of individual variations in the course of the disease and response to treatment. Immunosuppressive drugs such as corticosteroids are not recommended for long-term treatment due to unavoidable, severe adverse effects.",
keywords = "Adrenal cortex hormones, Immunosuppressive agents, Urticaria",
author = "Pigatto, {P. D.} and Marsili, {C. B.} and F. Ayala and O. Depit{\`a} and C. Gelmetti and A. Giannetti and G. Girolomoni and Vena, {G. A.} and N. Cassano and F. Ayala",
year = "2009",
language = "English",
volume = "144",
pages = "297--311",
journal = "Minerva dermatologica",
issn = "0392-0488",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "3",

}

TY - JOUR

T1 - Italian position paper on urticaria

AU - Pigatto, P. D.

AU - Marsili, C. B.

AU - Ayala, F.

AU - Depità, O.

AU - Gelmetti, C.

AU - Giannetti, A.

AU - Girolomoni, G.

AU - Vena, G. A.

AU - Cassano, N.

AU - Ayala, F.

PY - 2009

Y1 - 2009

N2 - The Italian Board on Urticaria has prepared a document focusing on the definition and classification of urticaria, taking into account the recent progress in identifying the causes, eliciting factors, and pathomechanisms of this disease. As urticaria has a profound impact on the quality of life, effective treatment is important. Therefore, specific treatment options for the management of urticaria are evaluated on the basis of the recent literature. Non-sedating H1 antihistamines are recommended as the first-line treatment as they have proven effective in several randomized double-blind controlled studies. Dosages higher than those recommended may be necessary in some cases. However, additional or alternative therapies may be required for different urticaria subtypes and in view of individual variations in the course of the disease and response to treatment. Immunosuppressive drugs such as corticosteroids are not recommended for long-term treatment due to unavoidable, severe adverse effects.

AB - The Italian Board on Urticaria has prepared a document focusing on the definition and classification of urticaria, taking into account the recent progress in identifying the causes, eliciting factors, and pathomechanisms of this disease. As urticaria has a profound impact on the quality of life, effective treatment is important. Therefore, specific treatment options for the management of urticaria are evaluated on the basis of the recent literature. Non-sedating H1 antihistamines are recommended as the first-line treatment as they have proven effective in several randomized double-blind controlled studies. Dosages higher than those recommended may be necessary in some cases. However, additional or alternative therapies may be required for different urticaria subtypes and in view of individual variations in the course of the disease and response to treatment. Immunosuppressive drugs such as corticosteroids are not recommended for long-term treatment due to unavoidable, severe adverse effects.

KW - Adrenal cortex hormones

KW - Immunosuppressive agents

KW - Urticaria

UR - http://www.scopus.com/inward/record.url?scp=68849090833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68849090833&partnerID=8YFLogxK

M3 - Article

C2 - 19528910

AN - SCOPUS:68849090833

VL - 144

SP - 297

EP - 311

JO - Minerva dermatologica

JF - Minerva dermatologica

SN - 0392-0488

IS - 3

ER -